Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in the Treatment of HIV-Infected Patients: Experience with the First 100 Patients from Qatar

BACKGROUND: To describe our experience with the use of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (EVG/COBI/FTC/TAF) in the treatment of HIV-infected patients in Qatar including both naïve and treatment experienced. We also report the reasons for switching to EVG/COBI/FTC/TAF in tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Soub, Hussam, Al-khal, A. Latif M., Alsoub, Deema, Awouda, Waleed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7441451/
https://www.ncbi.nlm.nih.gov/pubmed/32849932
http://dx.doi.org/10.1155/2020/1597839

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7441451/
https://www.ncbi.nlm.nih.gov/pubmed/32849932
http://dx.doi.org/10.1155/2020/1597839

Ejemplares similares